High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
about
Immune thrombocytopenia: recent progress in pathophysiology and treatment.The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia.A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpuraRituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.Eltrombopag-based combination treatment for immune thrombocytopenia
P2860
Q33413896-6DD67157-B902-4BAA-9B0E-C5FF79CD7154Q33419990-9E0E2BC9-700E-403E-AB5C-CD1B12AF2F71Q33422782-58444C5B-3E6B-4ADA-9A07-719CAF3FDF4CQ33430243-32E45704-A8DD-4198-99FE-E23C245CA1D2Q33443173-8C77935A-A4C2-4935-BF7A-2D8E84B36BCFQ42014891-CB85CB22-798B-402F-B30E-838C1AE851D1Q48113733-051C8375-3AAB-4BC9-8923-CF72C15D59B9Q48360142-ABEFABBD-26B4-4E59-B4B6-7972AFC73A47Q51736337-75F2F752-E835-4DDD-A62A-35147C5DB9B5Q57818187-AF19B94A-8DF4-40FC-92DA-3A4AD47DA127
P2860
High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
High response rate to low-dose ...... imary immune thrombocytopenia.
@ast
High response rate to low-dose ...... imary immune thrombocytopenia.
@en
type
label
High response rate to low-dose ...... imary immune thrombocytopenia.
@ast
High response rate to low-dose ...... imary immune thrombocytopenia.
@en
prefLabel
High response rate to low-dose ...... imary immune thrombocytopenia.
@ast
High response rate to low-dose ...... imary immune thrombocytopenia.
@en
P2093
P2860
P356
P1476
High response rate to low-dose ...... imary immune thrombocytopenia.
@en
P2093
Adrián Alejandro Ceballos-López
Brizio Moreno-Jaime
David Gómez-Almaguer
Guillermo J Ruiz-Argüelles
Guillermo J Ruiz-Delgado
José Carlos Jaime-Pérez
Luz Tarín-Arzaga
Mónica Sánchez-Cárdenas
P2860
P304
P356
10.1111/EJH.12102
P577
2013-04-02T00:00:00Z